The short version of Fifteen residues fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2025-09-21. Anything still debated is marked as such rather than presented as settled.
A freeze-dried sample is generally the most stable form and is commonly held at minus twenty degrees Celsius or lower for long-term keeping, with brief transfers at room temperature. The solid is hygroscopic, so vials are warmed to ambient temperature before opening to prevent condensation from degrading the contents. Light exposure and repeated temperature cycling are both avoided in routine handling. Storage over a desiccant is a common laboratory practice that limits moisture uptake during repeated access.
Once dissolved, the material is considerably less stable than the dry solid. Aqueous solutions are usually kept cold and used within a short window, and neutral or mildly acidic buffers are preferred over strongly alkaline conditions. Freeze-thaw cycles promote aggregation and loss of material to container surfaces, so dividing a batch into single-use aliquots is standard. Adsorption to plastic and glass can lower the measured concentration, meaning solution strength may need rechecking before an experiment.
Identity and purity are established with complementary methods rather than one test. Reverse-phase high-performance liquid chromatography separates the main peak from deletion sequences and oxidized variants, and its area percentage is the usual purity figure. Mass spectrometry confirms the expected molecular mass and can flag truncations or modifications that chromatography alone might miss. Amino acid analysis and peptide mapping add sequence-level confirmation, while residual counter-ion and water content are measured separately.
Doses in the literature are usually expressed in micrograms or nanograms per kilogram of body weight. Investigators have administered the peptide by several routes, including injection and oral delivery, depending on the question asked. Route and dose vary widely across studies, which complicates direct comparison of results. Many papers report effects at low doses, but the absence of a standardized protocol limits generalization. Reporting practice differs between research groups.
Some properties, such as the peptide's sequence and molecular mass, are firmly established. Other claims, particularly about mechanism and clinical benefit, remain open questions. Proposed mechanisms include effects on nitric oxide signaling and on cell migration, but these are hypotheses supported by limited evidence. Reviewers often note that the field lacks large controlled human trials. Positive animal findings are best treated as signals for further study rather than as settled conclusions.
Most published studies examine BPC-157 in animal models rather than in humans. Common subjects include rats and mice, and researchers often use models of tissue injury, surgery, or induced inflammation. Reported endpoints include healing rates, blood vessel formation, and markers of tissue repair. These designs provide controlled comparisons, but findings in animals do not automatically transfer to people. Human clinical data remain limited and are frequently described as preliminary.
| Property | Value | Notes |
|---|---|---|
| Dry powder storage | -20 °C or below | Desiccated and protected from light |
| Solution storage | 2-8 °C, short term | Aliquot to avoid freeze-thaw cycling |
| Reconstitution solvent | Water or buffered saline | Near-neutral pH is generally preferred |
| Identity confirmation | Mass spectrometry | Matches expected monoisotopic mass |
| Purity assessment | Reverse-phase HPLC | Reported as main-peak area percentage |
BPC-157 is a synthetic peptide built from fifteen amino acids, referred to in the literature as a pentadecapeptide. Its sequence was derived from a larger protein found in human gastric juice, commonly called body protection compound. Researchers first described the fragment in the early 1990s and named it after the parent protein plus a numeric identifier. The peptide does not correspond to a single marketed medicine; it is primarily a laboratory research material. Suppliers distribute it as a lyophilized powder intended for experimental use.
Published work on BPC-157 spans several decades and covers a wide range of experimental models. Much of the early literature reports outcomes in animal studies involving induced injury to the gastrointestinal tract, tendons, and other tissues. The volume of preclinical reports is large, while controlled human trials remain scarce. This imbalance is a recurring point of discussion, because animal findings do not automatically translate into human effects. Reviews often note that study designs differ substantially across laboratories.
Interest in the peptide has grown through online communities that discuss self-administered use, which sits outside formal research settings. Regulatory status varies by country, and in many jurisdictions the compound is not approved as a therapeutic product. Questions about optimal routes of administration, long-term effects, and dose-response relationships remain open. Published pharmacokinetic data in humans are limited, and much of what circulates in popular discussion is extrapolated from animal work rather than measured directly in people.
Laboratory research on this peptide has examined a wide and heterogeneous set of endpoints, including gastric ulcer models, tendon and ligament injury, wound closure, and intestinal inflammation. Most published findings come from rodent studies, and reported effect sizes are often large relative to controls. Because the compound has been tested across many unrelated injury models, the literature is frequently described as unusually broad for a single peptide. A substantial share of this work originates from a small number of research groups, which matters when assessing how widely results have been reproduced.
Evidence in humans is limited. Small clinical studies have examined the peptide in contexts such as ulcerative colitis and wound healing, but participant numbers are small and independent replication is scarce. It is not approved as a medicine by major regulatory agencies and is distributed mainly as a research material or compounded preparation. Long-term human safety data are not established, and questions about absorption through non-injected routes remain open rather than resolved. Claims about its effects are best read against these gaps.
BPC-157 is a synthetic peptide of fifteen amino acids, written in single-letter code as GEPPPGKPADDAGLV. The sequence corresponds to a partial fragment of a protein isolated from human gastric juice, described in early reports as body protection compound. The number 157 refers to a fragment designation in that work rather than to molecular mass. Initial descriptions appeared in the early 1990s, when the fragment was reported to protect gastrointestinal tissue in animal models. Commercial material is produced by solid-phase peptide synthesis rather than extracted from biological sources.
In a study by Belicka et al., six sediment cores from two shelf-basin transects in the Chukchi and Beaufort Seas of the Arctic Ocean were examined in order to compare the sources and preservation of organic carbon between the two differing depositional regimes. This study found an unexpected correlation between dinosterol and α-amyrin, which is found in terrestrial plants, in shelf and slope sediments, in particular the Beaufort Shelf, suggesting that dinoflagellates contribute significantly to phytoplankton abundance in areas of seasonal open water. Dinosterol was only observed above the permanent ice pack, suggesting that dinoflagellates are restricted to open waters, which in the Arctic occur near the shallow shelves. Consequently, dinosterol may be a potential indicator of the history of open water conditions.
EF-Tu (elongation factor thermo unstable) is a prokaryotic elongation factor responsible for catalyzing the binding of an aminoacyl-tRNA (aa-tRNA) to the ribosome. It is a G-protein, and facilitates the selection and binding of an aa-tRNA to the A-site of the ribosome. As a reflection of its crucial role in translation, EF-Tu is one of the most abundant and highly conserved proteins in prokaryotes. It is found in eukaryotic mitochondria as TUFM. As a family of elongation factors, EF-Tu also includes its eukaryotic and archaeal homolog, the alpha subunit of eEF-1 (EF-1A).
Pneumatic nebulization of mobile phase from the analytical column forming an aerosol. Aerosol conditioning to remove large droplets. Evaporation of solvent from the droplets to form dried particles. Particle charging using an ion jet formed via corona discharge. Particle selection – an ion trap is used to excess ions and high mobility charged particles. Measurement of the aggregate charge of aerosol particles using a filter/electrometer. The CAD like other aerosol detectors, can only be used with volatile mobile phases. For an analyte to be detected it must be less volatile than the mobile phase. More detailed information on how CAD works can be found on the Charged Aerosol Detection for Liquid Chromatography Resource Center.
While being branded, ten blood samples were collected, heart rate measurements were taken, and vocalizations recorded with the microphone. These samplings occurred at uneven intervals during a 25-minute period, from five minutes before to twenty minutes after branding. This study determined that mean concentrations of plasma epinephrine were higher for hot branded calves than for both freeze branded calves and sham branded calves. Epinephrine levels peaked at 30 seconds for hot branded calves and at 1 minute for freeze branded calves. Heart rates, hormone concentrations, and epinephrine levels, the study's primary pain proxy, were all elevated in hot-branded calves. In terms of vocalization, one hot-branded and two freeze-branded calves expressed distress during branding, although this may have been due to the absence of other cattle in the calf's field of view. Calves branded in the presence of other calves were more likely to vocalize, as would be expected from herd animals. Another study also using calves monitored their escape-avoidance reaction. The vertical movement of a calf during branding was used as an operational definition to measure avoidance of the brand. The experimenters concluded that hot-branded calves tried harder to escape their branding irons than either the freeze-branded or sham-branded calves.
Sources: en.wikipedia.org
This mating can cause bi-daily surges of prolactin which would normally occur in rodent pregnancy. Prolactin surges initiate the secretion of progesterone which maintains pregnancy and hence can initiate pseudopregnancy. The false maintenance of pregnancy exhibits the outward physical symptoms of pregnancy, in the absence of a foetus. Prolactin receptor activation is essential for normal mammary gland development during puberty in mice. Adult virgin female prolactin receptor knockout mice have much smaller and less developed mammary glands than their wild-type counterparts. Prolactin and prolactin receptor signaling are also essential for maturation of the mammary glands during pregnancy in mice.
== Adverse effects == In clinical trials, the most common adverse effects of sildenafil use included headache, flushing, indigestion, nasal congestion, and impaired vision, including photophobia and blurred vision. Some sildenafil users have complained of seeing everything tinted blue (cyanopsia). This cyanopsia can be explained because sildenafil, while selective for PDE5, does have some affinity for PDE6, which is the phosphodiesterase found in the retina. Patients thus taking the drug may experience colorvision abnormalities. Some complained of blurriness and loss of peripheral vision. In July 2005, the US Food and Drug Administration (FDA) updated labeling for tadalafil (Cialis), vardenafil (Levitra), and sildenafil (Viagra) to reflect a small number of post-marketing reports of sudden vision loss, while acknowledging that "...it is not possible to determine whether these oral medicines for erectile dysfunction were the cause of the loss of eyesight or whether the problem is related to other factors such as high blood pressure or diabetes, or to a combination of these problems." A careful review of pooled data from clinical trials containing well documented information about the dose and duration of exposure to the drug for a large number of patients, yields no evidence for an increased risk of non-arteritic anterior ischemic optic neuropathy or other adverse ocular events associated with PDE5 inhibitor use.
The two substrates of this enzyme are epipregnanolone and oxidised nicotinamide adenine dinucleotide phosphate (NADP+). Its products are 5β-dihydroprogesterone, reduced NADPH, and a proton. This enzyme belongs to the family of oxidoreductases, specifically those acting on the CH-OH group of donor with NAD+ or NADP+ as acceptor. The systematic name of this enzyme class is 3beta-hydroxy-5beta-steroid:NADP+ 3-oxidoreductase. Other names in common use include 3beta-hydroxysteroid 5beta-oxidoreductase, and 3beta-hydroxysteroid 5beta-progesterone oxidoreductase.
Sources: en.wikipedia.org
=== Ka--Kj === Henri B. Kagan (born 1930) French chemist, pioneer of asymmetric catalysis, 2001 Wolf Prize in Chemistry Isabella Karle (1921–2017), American chemist instrumental for extracting plutonium chloride from a mixture containing plutonium oxide Jerome Karle (1918–2013), 1985 Nobel Prize in Chemistry for the direct analysis of crystal structures by X-ray scattering Paul Karrer (1889–1971), Swiss organic chemist known for research on vitamins, 1937 Nobel Prize in Chemistry Alan R. Katritzky (1928–2014), British-American organic chemist, pioneer of heterocyclic chemistry Joyce Jacobson Kaufman (1929–2016), American chemist and inventor of conformational topology Melinda H. Keefe (PhD 2001), American chemist known for identifying solvents that can be used to remove dirt without damaging layers of paint August Kekulé (1829–1896), German organic chemist known for the theory of chemical structure, especially the structure of benzene John Kendrew (1917–1997), British biochemist and crystallographer known for solving the structure of myoglobin, 1962 Nobel Prize in Chemistry Ann Kiessling (born 1942), American chemist and reproductive biologist known for discovering reverse transcriptase activity in normal human cells Ann Kimble-Hill (21st century), American biochemist studying structure-function relationships of membrane proteins and lipids Petrus Jacobus Kipp (1808–1864), Dutch chemist, inventor of Kipp's apparatus Johan Kjeldahl (1849–1900), Danish chemist who developed a method for determining the amount of nitrogen in organic compounds
== Rolfing == Schleip has been a rolfing instructor since 1988 and maintains a part-time private practice in Munich. He served as a member on the board of directors for the European Rolfing Association in Munich from 1995 to 1999, and on the ethics committee from 1999 to 2003, as well as a member of the international advisory board of the Rolf Institute in Boulder from 2000 to 2005. In 2006, he became the research director of the European Rolfing Association. He also is vice president of Ida P. Rolf Research Foundation In 2013, he received the RISI Award for "Excellence in Research" by the Rolf Institute.
In sensory neurons, action potentials result from an external stimulus. However, some excitable cells require no such stimulus to fire: They spontaneously depolarize their axon hillock and fire action potentials at a regular rate, like an internal clock. The voltage traces of such cells are known as pacemaker potentials. The cardiac pacemaker cells of the sinoatrial node in the heart provide a good example. Although such pacemaker potentials have a natural rhythm, it can be adjusted by external stimuli; for instance, heart rate can be altered by pharmaceuticals as well as signals from the sympathetic and parasympathetic nerves. The external stimuli do not cause the cell's repetitive firing, but merely alter its timing. In some cases, the regulation of frequency can be more complex, leading to patterns of action potentials, such as bursting.
Mamadou Amadou Ly - Educationist, first African to be awarded the Yidan Prize, Time Magazine 100 Most influential people in the world (2026), Senegal. Amsatou Sow Sidibé- academic, lawyer and politician, Senegal Adji Bousso Dieng - assistant Professor of artificial intelligence, First African Faculty school of Engineering and applied science, Princeton University, Senegal. Ayuba Suleiman Diallo - Fulani Muslim prince and merchant, from Bundu, who was captured and sold to European slave traders after having just sold slaves himself. Ba Mamadou Mbare – former president of the Senate of Mauritania and former acting president of Mauritania, in office 15 April 2009 – 5 August 2009. The first black leader of Mauritania Baaba Maal – Singer and guitarist – Senegal Babacar Ba - former minister of finance, Foreign minister of Senegal. Cheikh Tidiane Gadio - Diplomat, former Minister of State, Minister of Foreign Affairs, Senegal Cherif Mohamed Aly Aidara - Shi'i religious leader, NGO founder, and international development leader Cheikh Hamidou Kane Mathiara - former Minister of the Armed Forces, Senegal Daouda Sow (politician)- Politician and legislator, former Minister and former president of the National Assembly, Senegal Doudou Ka - Former Minister of Economy, Planning and Cooperation, Senegal. Doudou Thiam - First Foreign Minister, Senegal. Djibo Leyti Kâ – Held multiple ministerial positions Including Foreign Affairs, National Education, Interior, Communication etc. in Senegal Fatoumata Ka - first female mayor in Senegal, mayor of the commune of Diourbel.
Sources: en.wikipedia.org
Low temperature slows the chemical reactions, such as oxidation and hydrolysis, that break down a peptide chain. Water and oxygen are the main drivers of degradation, so a cold and dry environment extends usable life. Actual shelf life depends on the batch, the salt form, and the container.
It normally reports the share of the chromatographic signal that belongs to the main peak, not a measure of activity. A high figure means few related substances were detected under the stated method and wavelength. Different laboratories and methods can return different values for the same material.
Retention time alone is weak evidence, because unrelated peptides can elute at similar positions. Amino acid analysis or peptide mapping gives stronger sequence information when a mass spectrometer is unavailable. Most laboratories still treat mass confirmation as the standard step for verifying the correct compound.
Human data are limited. Most evidence comes from animal experiments and from small or uncontrolled reports. The absence of large trials means clinical effects and safety are not firmly established.